Hepatitis C Management in Special Populations
Summary
- AASLD/IDSA guidance panel recommends DAA regimens as preferred therapy for genotype 2-6 HCV infection in patients with HCV/HIV coinfection (Management Guidelines)[AASLD-IDSA HCV]
- EASL guidance panel recommends DAA regimens for genotype 2-6 HCV infection in patients with HCV/HIV coinfection (Management Guidelines)[EASL HCV]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content